Influenza Vaccines in The United States Market to Witness Substantial Growth By 2025

July 09, 2020

According to the research report titled ‘Influenza Vaccines in the United States Market Size, Trends, Opportunities and Growth Potential’, available with Market Study Report LLC, influenza vaccines in the United States market is expected to grow substantially during 2019-2025.

Factors such as introduction of quadrivalent influenza vaccines, government and advisory bodies recommendations to undertake widespread vaccination drive against influenza infection, approval of new influenza vaccines, and increased cognizance of disease among population will contribute towards the growth of influenza vaccine in the United States market.

Request sample copy of this Report:

The report comprises of an in-depth analysis of US influenza vaccines market and offer information about prevailing trends, opportunities, growth potentials, and size. In addition, it includes historical data of the industry for 2013-2018 and predictions over 2019-2025.

A comprehensive analysis of the United States influenza vaccines market is done in terms of both volume and value. The research document provides clear insights into present and future developments of influenza vaccines market in the US.

The report studies the data about total number of children and adults treated with influenza vaccines in US during 2013-2018 to deliver estimations till 2025. Updated insights regarding allocation, supply, and production of influenza vaccines by major firms in the United States are provided in the report.

Factors such as effectiveness, distribution & demand, and pricing of influenza vaccines are considered while performing extensive assessment of the industry. The report includes meticulous evaluation of the technique and distribution channel of influenza vaccination. In addition, it covers the reimbursement scenario and provides an understandable view of regulatory framework.

The analysis of clinical trials, evaluation of promising influenza vaccines in clinical development, and swift diagnostic testing for handling influenza are enlisted in the report. Various aspects such as licensing agreement as well as strategies like distribution, merger & acquisition, and collaboration undertaken by leading players are scrutinized in the report. The growth drivers and restraints of influenza vaccines in the United States market are explored in the report.

Major companies that define the competitive landscape of influenza vaccines in the United States market are Biondvax Pharmaceuticals Ltd, Mitsubishi Tanabe Pharma, Daiichi-Sankyo, Novavax, AstraZeneca, GlaxoSmithKline (GSK), Sanofi Pasteur, and Seqirus among others.

Chat with us